from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0937c/mku

LFCtreatmentdescriptionclass of inhibitor

-0.417

Amikacinug/mL Amikacintranslation

-0.883

Cap5-10ug/mL Capreomycintranslation

-0.863

Rox10-50 ug/mL Roxithromycintranslation

-0.494

SM2-5 ug/mL Streptomycintranslation

-1.805

Tet5-10 ug/mL Tetracyclinetranslation

0.356

Rif0.2-5ug/mL Rifampicintranscription

0.131

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.078

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

1.706

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

1.210

CPZ10-50 ug/mL Chlorpromazinerespiration

1.151

Clofazimine10-13 ug/mL Clofaziminerespiration

0.433

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

1.408

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

2.621

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.747

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.864

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.242

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

1.733

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

1.102

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.126

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.915

KCN5-20 ug/mL Potassium cyaniderespiration

0.404

NaN30.2-2 mM Sodium aziderespiration

0.246

Nigericin50 uM Nigericinrespiration

1.146

TRC10-150 ug/mL Triclosanrespiration

3.386

TRZ10-25 ug/mL Thioridazinerespiration

-1.211

Valinomycin0.5-10 uM Valinomycinrespiration

-0.375

ZnSO42 mM ZnSO4respiration

-0.331

menadione6-10 ug/mL Menadionerespiration

-0.089

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.787

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.456

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.611

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.723

NRP_1Non-replicating persistence stage 1dosRassociated

-0.108

Amp0.2mg/mL AmpicillincellWall

-0.235

Cephalexin20-100 ug/mL CephalexincellWall

-0.485

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.251

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.402

EMB10-20 ug/mL EthambutolcellWall

-0.412

Eta12-40 ug/mL EthionamidecellWall

-1.032

INH0.2-0.4 ug/mL IsoniazidcellWall

0.105

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.342

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.292

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.277

BZA0.12 mg/mL BenzamidearomaticAmides

-0.149

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.682

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.344

H2O24 mM hydrogen peroxideDNAdamaging

-0.431

Levo10 ug/mL LevofloxacinDNAdamaging

-0.699

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.105

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.319

Oflox5-10 ug/mL OfloxacinDNAdamaging

-1.042

UVUV-irradiationDNAdamaging

0.660

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.299

Antimycin12.5-50 ug/mL Antimycin A?

-0.293

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.106

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.088

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.413

PA8240.2-2 ug/mL PA-824?

-0.163

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.064

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.250

Verapamil50 uM Verapamil?

-0.064

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.017

methoxatin10-20 ug/mL Methoxatin?